CareDx Reports First Quarter 2023 Results

Go back to CareDx Reports First Quarter 2023 Results

BTIG Downgrades CareDx, Inc (CDNA) to Neutral 'Given various uncertainties'

May 11, 2023 6:14 AM EDT

BTIG analyst Sung Ji Nam downgraded CareDx, Inc (NASDAQ: CDNA) from Buy to Neutral.

The analyst comments "CareDx announced on its Q1 call that they are withdrawing its guidance, which is more Draconian than we called for in our preview for CDNA to... More